Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

by Bai, J., Batrakou, D.G, Boross-Harmer, S., Broad, R., Brophy, F., Butler, M.O, Dumbrava, E.E, Duose, D.Y, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gerry, A.B, Ghobadi, A., Hong, D.S, Kebriaei, P., Marks, D., Navenot, J.-M, Norry, E., Pachynski, R.K, Sanderson, J.P, Sauer, A., Solis, L.M, Sullivan, R., Wang, R., Wolchinsky, Z.
Published 2022

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

by Bachier, C., Bai, J., Batrakou, D., Blumenschein, G.R, Broad, R., Devarakonda, S., Doger de Spéville, B., Edelman, M.J, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gainor, J., Gerry, A., Govindan, R., Heymach, J.V, Holdich, T., Hyland, N., Johnson, M., Lam, V.K, Marks, D., Moreno, V., Navenot, J.-M, Norry, E., Olszanski, A.J, Pentony, M.M, Sanderson, J.P, Wolchinsky, Z.
Published 2022